20 Participants Needed

Near Infrared Spectroscopy for Single Ventricle Heart

JW
Overseen ByJOSHUA WONG, MD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Advocate Hospital System
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 4 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this study is to assess the utility of renal near infrared spectroscopy in the outpatient setting during the interstage period. The primary aim will be to determine the correlation between oxygen extraction ratio ((arterial pulse oximetry - renal near infrared spectroscopy value)/arterial pulse oximetry value) with need for inpatient admission or intervention. Secondary aims will be to determine the correlation of the oxygen extraction ratio with weight gain, neurodevelopment, unexpected admissions, systemic ventricular strain by echocardiography, and Glenn hospitalization admission characteristics.

Will I have to stop taking my current medications?

The trial information does not specify whether participants must stop taking their current medications.

What data supports the effectiveness of the treatment Near Infrared Spectroscopy for Single Ventricle Heart?

Research suggests that using near-infrared spectroscopy (NIRS) during heart surgery in infants can help predict potential kidney problems and adverse outcomes, which might improve patient monitoring and care.12345

Is Near Infrared Spectroscopy (NIRS) safe for use in humans?

Near Infrared Spectroscopy (NIRS) is generally considered safe as it is a noninvasive method used to monitor tissue oxygenation. However, studies have shown that during procedures, some patients experienced adverse events like desaturation and arrhythmia, which were detected by NIRS. It is important to note that these events were related to the medical procedures rather than the use of NIRS itself.678910

How does near-infrared spectroscopy treatment differ from other treatments for single ventricle heart conditions?

Near-infrared spectroscopy (NIRS) is unique because it is a non-invasive method that continuously monitors regional tissue oxygenation, allowing real-time assessment of oxygen supply and demand in the body. Unlike other treatments that may focus on direct intervention, NIRS provides valuable information on how well oxygen is being delivered to tissues, which can be crucial for managing patients with single ventricle heart conditions.411121314

Research Team

JW

Joshua Wong, MD

Principal Investigator

Advocate Children's Hospital

Eligibility Criteria

This trial is for individuals with a heart condition known as Single Ventricle Heart. It's specifically looking at patients in the interstage period, which is the time between their first and second heart surgeries.

Inclusion Criteria

My infant is not hospitalized.
My infant is scheduled for the Glenn operation.
My child is younger than 6 months.
See 1 more

Exclusion Criteria

My child is older than 6 months.
My infant has ongoing jaundice.
My infant had a skin injury from a NIR sensor in the hospital.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Interstage Monitoring

Participants have renal near infrared spectroscopy recorded in clinic to assess oxygen extraction ratio and its correlation with clinical outcomes

1 year
Regular clinic visits

Follow-up

Participants are monitored for safety and effectiveness after the interstage monitoring period

4 weeks

Treatment Details

Interventions

  • Near Infrared Spectroscopy
Trial Overview The study tests how well renal near infrared spectroscopy (a non-invasive method to monitor oxygen levels in tissues) can predict hospital admissions or interventions during outpatient care in this patient group.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: NIRS useExperimental Treatment1 Intervention
Patients will have renal near infrared spectroscopy recorded in clinic.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Advocate Hospital System

Lead Sponsor

Trials
6
Recruited
490+

Findings from Research

In a study of 91 infants with single-ventricle physiology after stage 1 palliation, cerebral near-infrared spectroscopy (NIRS) values were significantly lower in patients with low cardiac output (LCO) compared to those with normal output, particularly at 1, 6, and 12 hours post-surgery.
Cerebral NIRS values at 6 hours post-surgery were found to be a reliable indicator for detecting LCO, with a cut-off value of ≤57% showing 91% sensitivity and 72% specificity, although NIRS did not predict other adverse outcomes like cardiac arrest or mortality.
Is there an association of near-infrared spectroscopy with low cardiac output and adverse outcomes in single-ventricle patients after stage 1 palliation?Doctor, P., Aggarwal, S., Garcia, R.[2023]
Monitoring cerebral and renal oxygen levels using near-infrared spectroscopy (NIRS) during congenital cardiac surgery can help predict serious outcomes like ECMO or death, especially when NIRS values fall below 45% for cerebral and 40% for renal.
The study found that lower renal NIRS values (below 30%) are associated with longer stays in the intensive care unit, indicating that NIRS can be a useful tool for assessing patient recovery post-surgery.
Prognostic value of perioperative near-infrared spectroscopy during neonatal and infant congenital heart surgery for adverse in-hospital clinical events.Dodge-Khatami, J., Gottschalk, U., Eulenburg, C., et al.[2014]
In a study of 48 infants undergoing cardiac surgery, intra- and postoperative renal near-infrared spectroscopy (NIRS) monitoring showed a strong correlation with renal insufficiency, particularly on postoperative day 1.
A mean renal saturation below 80% predicted renal insufficiency with 100% sensitivity and 75% specificity, suggesting that NIRS could serve as an early, noninvasive marker for renal issues after surgery.
Near-infrared spectroscopy monitoring to predict postoperative renal insufficiency following repair of congenital heart disease.Colasacco, C., Worthen, M., Peterson, B., et al.[2014]

References

Is there an association of near-infrared spectroscopy with low cardiac output and adverse outcomes in single-ventricle patients after stage 1 palliation? [2023]
Prognostic value of perioperative near-infrared spectroscopy during neonatal and infant congenital heart surgery for adverse in-hospital clinical events. [2014]
Near-infrared spectroscopy monitoring to predict postoperative renal insufficiency following repair of congenital heart disease. [2014]
Change in regional (somatic) near-infrared spectroscopy is not a useful indicator of clinically detectable low cardiac output in children after surgery for congenital heart defects. [2022]
Perioperative monitoring in high-risk infants after stage 1 palliation of univentricular congenital heart disease. [2015]
Near infrared spectroscopy monitoring in the pediatric cardiac catheterization laboratory. [2014]
Intraoperative renal near-infrared spectroscopy indicates developing acute kidney injury in infants undergoing cardiac surgery with cardiopulmonary bypass: a case-control study. [2022]
Low renal oximetry correlates with acute kidney injury after infant cardiac surgery. [2021]
Effects of ventilation modalities on near-infrared spectroscopy in surgically corrected CDH infants. [2018]
10.United Statespubmed.ncbi.nlm.nih.gov
Cardiac Surgery-Associated Kidney Injury in Children and Renal Oximetry. [2019]
Near-infrared spectroscopy as continuous real-time monitoring for kidney graft perfusion. [2021]
Near infrared spectroscopy monitoring during pediatric aortic coarctation repair. [2006]
13.United Statespubmed.ncbi.nlm.nih.gov
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children. [2020]
[Near-infrared spectroscopy during cardiopulmonary resuscitation and mechanical circulatory support: From the operating room to the intensive care unit]. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security